Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BPH Energy is an Australian-based investment company with a diversified portfolio spanning the biotechnology and energy sectors. In the healthcare space, its primary focus is on medical devices and drug discovery through its investee companies, Cortical Dynamics and Molecular Discovery Systems. Cortical Dynamics has developed the Brain Anaesthesia Response Monitor (BARM), a next-generation EEG engine designed to better monitor a patient's brain activity during surgery to prevent intra-operative awareness. Molecular Discovery Systems is focused on the validation of HLS5 as a novel tumor suppressor gene for potential cancer treatments. The company is publicly traded on the Australian Securities Exchange and continues to advance its medical technologies toward global commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BPH Energy.